Brief: Zoetis Says Co Priced Offering Of $1.75 Billion Aggregate Principal Amount Of 0.25% Convertible Senior Notes Due 2029
Dec 16 (Reuters) - Zoetis Inc ZTS.N: ZOETIS ANNOUNCES PRICING OF $1.75 BILLION CONVERTIBLE SENIOR NOTES OFFERING ZOETIS INC - PRICED OFFERING OF $1.75 BILLION AGGREGATE PRINCIPAL AMOUNT OF 0.25% CONVERTIBLE SENIOR NOTES DUE 2029 Source text: ID:nBw3d9SHva Further company coverage: ZTS.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zoetis
See all newsBrief: Zoetis Receives FDA Approval For Convenia® Rtu For Dogs (Cefovecin Injectable Suspension), Helping More Medium And Large Dogs Access Single-Injection Treatment
Brief: FDA Approves Ready-To-Use Cefovecin Injectable For Treatment Of Certain Skin Infections In Dogs
U.S. RESEARCH ROUNDUP-Masco, Sherwin-Williams, Vulcan Materials
Zoetis gets US FDA emergency use nod for treatment for screwworm in dogs
Brief: FDA Issues Emergency Use Authorization For Simparica Trio To Treat New World Screwworm In Dogs, Puppies